Abu Dhabi • 26 September 2019
Non-communicable diseases (NCDs) pose one of the greatest health risks for humanity, demanding new answers and creative solutions from health systems and healthcare professionals, according to the International Pharmaceutical Federation (FIP). In a Statement of Policy published today, FIP makes clear the value of pharmacists in the global fight against NCDs.
“This policy statement renews the commitment of the pharmacy profession to the prevention of NCDs, and the optimal detection and care of patients living with NCDs,” said Ms Eeva Teräsalmi, FIP vice president and chair of its NCD Policy Committee.
“There are a number of NCDs, including cardiovascular disease, diabetes, asthma, cancer and mental illness, for which there is strong evidence of the role and vital importance of the pharmacist in patient care. Pharmacists can provide focused interventions, specialised counselling and care coordination, improving patient engagement to achieve better outcomes,” Ms Teräsalmi explained.
FIP’s 144 national member organisations across 103 countries and territories adopted the new policy statement earlier this week, which describes a number of ways in which the burden of NCDs may be reduced. Prevention and control of NCDs require interventions that are cost-effective, affordable by the patient and/or health systems and feasible, based on patient-specific factors as well as local resources, FIP says.
In particular, the statement urges governments to develop strategies and health programmes for the prevention and management of NCDs where the role of pharmacists is defined, recognised and enabled, and to promote and set the conditions for interprofessional cooperation, and increased integration of community pharmacies within the primary care network. There is a specific need for programmes integrating pharmacists, which can tackle poor adherence to longterm therapies in patients with NCDs, the policy statement adds.
Note for editors
According to the World Health Organization (WHO), more than 36 million people die annually from NCDs, representing over 60% of deaths worldwide, 15 million of which occur before the age of 70 years. The new FIP Statement of Policy follows the publication of FIP’s report “Beating non-communicable diseases in the community”, which considers newly available evidence on the epidemiology of NCDs in an ageing world and established and emerging roles of pharmacists in primary health care, and was produced by FIP’s Working Group on the Role of Pharmacists in Non-Communicable Diseases.
Ms Teräsalmi is available for interview on request.
The International Pharmaceutical Federation (FIP) is the global federation of national associations of pharmacists, pharmaceutical scientists and pharmacy educators, and is in official relations with the World Health Organization. Through its 151 member organisations, it represents over four million practitioners and scientists around the world. www.fip.org
Lin-Nam Wang, Head of Communications and Marketing
Tel +31 6 316 29160